UBS Maintains Buy Rating for Keurig Dr Pepper with $40 Price Target.

UBS analyst Peter Grom reiterated a Buy rating on Keurig Dr Pepper with a price target of $40.00, citing positive corporate insider sentiment and a strong consumer defensive sector. Grom has a 54.05% success rate and an average return of -2.8%. The company's shares opened at $31.00, with a market cap of $42.25B and P/E ratio of 31.17.